Literature DB >> 22383230

Characteristics of multiple sclerosis in aboriginals living in British Columbia, Canada.

Jameelah Saeedi1, Peter Rieckmann, Irene Yee, Helen Tremlett.   

Abstract

OBJECTIVES: The objectives of this study were to identify and describe the demographic and clinical characteristics of multiple sclerosis (MS) in aboriginals in British Columbia (BC), Canada and compare these findings with non-aboriginal MS patients.
METHODS: This retrospective chart and database review accessed patient information from the linked BC-wide MS clinical and genetics databases. Data gathered included: demographics (age, sex and ethnicity); clinical characteristics (MS onset date, disease course and disability scores (Expanded Disability Status Scale [EDSS]). Aboriginals were identified via the database linkage augmented by physician and nurse recall. Two non-aboriginal comparator groups with definite MS were selected. Group one included all definite MS patients in the BC MS database, and group two comprised MS patients matched by sex, age at onset and initial disease course. Patient characteristics were compared using the Student's t-test, chi-squared test, and Kaplan-Meier survival analysis was used to examine disease progression (time to sustained and confirmed EDSS 6)
RESULTS: We identified 26 aboriginals with MS, of which 19/26 (73%) were female, 23/26 (89%) had relapsing-onset MS and a mean onset age of 31.1 years. There were no significant differences between the MS aboriginals and the non-matched (n = 5708) comparator group with respect to age, sex or disease course (p > 0.1), However, aboriginals progressed more rapidly to EDSS 6 from disease onset (p < 0.001) when compared with the matched and unmatched comparator groups.
CONCLUSION: We identified a small, but important cohort of aboriginals with MS; being the largest identified to date. There was evidence of more rapid MS progression in aboriginals compared with non-aboriginals.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22383230     DOI: 10.1177/1352458512436595

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  7 in total

Review 1.  Multiple Sclerosis in Latin Americans: Genetic Aspects.

Authors:  Victor M Rivera
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08       Impact factor: 5.081

2.  Multiple sclerosis in First Nations Canadians: A pilot comparison study.

Authors:  Ruth Ann Marrie; Nicholas Hall; A Dessa Sadovnick
Journal:  Mult Scler J Exp Transl Clin       Date:  2016-08-29

Review 3.  Lower prevalence of multiple sclerosis in First Nations Canadians.

Authors:  Ruth Ann Marrie; Stella Leung; Nancy Yu; Lawrence Elliott
Journal:  Neurol Clin Pract       Date:  2018-02

4.  Generational changes in multiple sclerosis phenotype in North African immigrants in France: A population-based observational study.

Authors:  Clotilde Nardin; Clotilde Latarche; Marc Soudant; Camille Dahan; Maud Michaud; Sophie Pittion-Vouyovitch; Francis Guillemin; Marc Debouverie; Guillaume Mathey
Journal:  PLoS One       Date:  2018-03-27       Impact factor: 3.240

5.  Identification of brain antigens recognized by autoantibodies in experimental autoimmune encephalomyelitis-induced animals treated with etomoxir or interferon-β.

Authors:  Anne Skøttrup Mørkholt; Kenneth Kastaniegaard; Michael Sloth Trabjerg; Gopana Gopalasingam; Wanda Niganze; Agnete Larsen; Allan Stensballe; Søren Nielsen; John Dirk Nieland
Journal:  Sci Rep       Date:  2018-05-04       Impact factor: 4.379

6.  CPT1A plays a key role in the development and treatment of multiple sclerosis and experimental autoimmune encephalomyelitis.

Authors:  Anne Skøttrup Mørkholt; Michael Sloth Trabjerg; Michal Krystian Egelund Oklinski; Luise Bolther; Lona John Kroese; Colin Eliot Jason Pritchard; Ivo Johan Huijbers; John Dirk Vestergaard Nieland
Journal:  Sci Rep       Date:  2019-09-16       Impact factor: 4.379

7.  Dysregulation of metabolic pathways by carnitine palmitoyl-transferase 1 plays a key role in central nervous system disorders: experimental evidence based on animal models.

Authors:  Michael Sloth Trabjerg; Anne Skøttrup Mørkholt; Jacek Lichota; Michal Krystian Egelund Oklinski; Dennis Christian Andersen; Katrine Jønsson; Kasper Mørk; Marie-Louise Nibelius Skjønnemand; Lona John Kroese; Colin Eliot Jason Pritchard; Ivo Johan Huijbers; Parisa Gazerani; Angelique Corthals; John Dirk Vestergaard Nieland
Journal:  Sci Rep       Date:  2020-09-24       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.